The maturation process of basal cells in craniopharyngiomas was studied using a panel of lectins, and antibodies against cytokeratin 13 and bcl-2 protein, using oral mucosa for comparison. Seven lectins were employed: peanut (<I>Arachis hypogaea</I>) agglutinin, <I>Dolichos biflorus</I> agglutinin (DBA), <I>Ulex europaeus</I> agglutinin-I (UEA-I), soybean agglutinin, <I>Ricinus communis</I> agglutinin-I, succinyl wheat germ agglutinin, and <I>Pisum sativum</I> agglutinin. DBA and cytokeratin 13 stainings of the suprabasal cells in craniopharyngiomas were comparable to those of the oral mucosa, but not to those of the skin. Staining patterns of the basal cells in the oral mucosa and craniopharyngiomas were generally similar, but UEA-I binding and bcl-2 protein expression in suprabasal cells differed. The difference appeared to be due to a disturbance in the differentiation of the basal cells, because only a small fraction of the basal cells followed a normal maturation process in craniopharyngiomas in comparison to the oral mucosa. The expression of bcl-2 protein may be involved in the pathogenesis of craniopharyngiomas.
Introduction
Craniopharyngioma is a squamous cell neoplasm considered to be derived from Rathke's cleft rem nants."' Craniopharyngiomas consist of layers similar to the skin and are, therefore, difficult to differentiate from epidermoid cysts, especially when an adamantinomatous component is lacking. Some authors consider that craniopharyngiomas and epidermoid cysts should be classified together because there are no clear distinguishing characteristics '21,211 although craniopharyngioma lacks the keratin layer seen in epidermoid cysts, and there are differences in clinical behavior. An alter native origin for craniopharyngioma is differentia tion from mucosal cells rather than epidermal cells.32>
The tumorigenesis may be clarified by in vestigating the localization of cytokeratin subunits or lectins, since specific patterns of cytokeratin polypeptides characterize a given epithelial cell type," and lectins are potent markers of changes in cell membrane glycoconjugates associated with differen tiation or neoplastic transformation.'," ' The lectin histochemistry of squamous cell epithelium has been extensively investigated in the skin and oral mucosa.9, '0,13,18,20,23,25,29,33,34) Lectins bind to specific layer(s) of the normal stratified squamous epithelium depending on the extent of differentiation, and there are distinct binding patterns determined by the loca tion of the epithelium."'
The bcl-2 proto-oncogene product acts to block programmed cell death,',"' and occurs in lymphoid tissue, hematopoietic tissue, glandular epithelium, complex differentiating epithelium such as the skin and intestine characterized by long-lived stem cells, and long-lived postmitotic cells such as neu rons. 8'14,16' In the stratified squamous epithelium, bcl-2 expression is confined to the basal cell layer at variable frequencies. 16' The bcl-2 gene may be impor tant in cell development, maturation,") and in the pathogenesis of epithelial malignancies.") This study investigated lectin binding patterns and localization of cytokeratin 13 and bcl-2 protein in craniopharyngiomas, compared with the oral mucosa, to evaluate the possible common origin of oral mucosa and craniopharyngioma from Rathke's pouch differentiated from primitive stomodeum.
Materials and Methods
This study examined 10 surgical specimens of craniopharyngiomas and eight normal specimens of the oral mucosa (4 non-keratinized buccal mucosa and 4 keratinized mucosa of the gingiva or hard palate), five derived from autopsy specimens and the other three from surgical specimens of normal tissue surrounding primary lesions. The blood group of each patient was determined. The tissue specimens were fixed in 10% formalin and embedded in paraffin. Cytokeratin 13 immunostaining used deparaffin ized sections incubated with 3% H202 for 20 min utes, and pretreated with 0.1% trypsin (Sigma type 3; Tris buffer, pH 7.6, with 0.1% CaC12) for 10 min utes. Non-specific binding of antibody was blocked by 5% skim milk for 30 minutes. Antibody to cyto keratin 13 (1:100) (Sigma Chemical) was applied overnight at 4°C followed by biotinylated secondary antibody (anti-mouse immunoglobulin G; Sigma Chemical) and avidin-biotin-peroxidase complex as described above.
Immunostaining for bcl-2 protein used an antigen retrieval method to obtain constant results from for malin-fixed paraffin-embedded sections. Rehydrated slides were placed in 10 mM citrate buffer (pH 6.0), and heated in a microwave oven at 800 W twice for 5 minutes. After cooling for 20 minutes, the slides were rinsed in distilled water and immunostained with anti-human bcl-2 oncoprotein (1:50) (Dako, Glostrup, Denmark) and LSAB kit (Dako). Negative control was obtained by omitting the reaction of the primary antibody. Lectin histochemistry: Representative lectin bind ing patterns of the oral mucosa are shown schematically in Fig. 1 . PNA binding to the tumors and the oral mucosa varied (Fig. 2 ). In the tumor specimens, PNA always bound to cells around the In the oral mucosa samples, PNA bound irregularly to the basal and spinous layers, while the surface layer was stained more con stantly.
After neuraminidase treatment, PNA stain ing occurred diffusely in all layers of both tumor and oral mucosa specimens.
DBA bound to the suprabasal cells in eight of 10 tumor specimens (Fig. 3) , and only to the cells around the keratinized nodules in the other two. Binding to the keratinized nodules was weak or en tirely absent. No DBA binding to the basal cells was seen, and there was no change after neuraminidase treatment. All of these findings were independent of blood group. Similarly, DBA staining was seen in the suprabasal layer of the non or para-keratinized oral mucosa (Fig. 1 ). The surface layer was most in tensely stained. In contrast, DBA staining was com pletely absent in the ortho-keratinized gingival mu cosa of one specimen of blood type 0, but other non or para-keratinized specimens of blood type O were stained by DBA.
UEA-I staining was limited to cells around keratinized granules in adamantinomatous areas (Fig. 4 left) , and only faint, sporadic staining in the uppermost layer of squamous areas (Fig. 4 center) . Exceptionally, one squamous-type tumor exhibited sporadic staining in the basal layer. UEA-I binding was totally absent except for blood vessels in two tumor specimens, one adamantinomatous and one squamous papillary types. Neither included keratin ized granules. Both patients belonged to blood group B, but the absence of staining was not blood group-dependent because one specimen from a pa tient with blood group B showed staining patterns similar to those from patients with other blood groups. In contrast, DBA staining occurred diffusely or heterogeneously in the suprabasal layer of the oral mucosa (Fin. 4 right). PSA diffusely stained the oral mucosa except for the upper spinous and surface layers (Fig. 5 right) .
Squamous-type craniopharyngioma
showed similar findings, with PSA binding absent in the surface layer (Fig. 5 center) . PSA diffusely stained the adamantinomatous type ( Fig. 5 left) , but cells around the keratinized bodies and surface of the squamous-like areas showed no binding.
RCA-I and s-WGA stained almost all cells of both tumor and oral mucosa specimens, although the basal cells were sometimes stained weakly. SBA stain ed only suprabasal cells in both tumor and oral mucosa specimens. Neuraminidase treatment caused the reactivity to often extend to the basal layer in the oral mucosa. In craniopharyngiomas, most of the basal cells of the adamantinomatous areas remained unstained, but the basal cells in the squamous areas showed strong reactivity. x 100. Cytokeratin 13: Cytokeratin 13 was present in the suprabasal layer of eight of 10 craniopharyngiomas (Fig. 6) . The other two showed weak staining only around the keratinized granules. A similar distribu tion was found in the oral mucosa, but one ortho keratinized sample showed reactivity in the basal layer with sporadic binding to the suprabasal layer.
bcl-2 protein: In the oral mucosa, bcl-2 protein was present only in the cytoplasm of the basal cells, but the number of positive cells and the staining in tensity varied (Fig. 7 left) . bcl-2 protein was present in most basal and suprabasal cells in nine of 10 craniopharyngiomas.
The other squamous-type tumor contained fewer bcl-2-positive cells scattered in both the basal and suprabasal layers. The propor tion of positive cells varied from place to place. Cells around the keratinized granules of adaman tinomatous type were often not stained. The staining intensity was usually weak in the basal cells in con trast to the infiltrating lymphocytes, but some suprabasal cells were highly stained. Basal cells tend ed to be stained more frequently than the suprabasal cells in the adamantinomatous type (Fig. 7 center) , while the suprabasal cells were more intensely and frequently stained than the basal cells in squamous type tumor (Fig. 7 right) . In all specimens, some in filtrating lymphocytes were highly stained, but other structures such as endothelial cells were usually not stained. 
Discussion
This study found the binding patterns of lectins and anti-cytokeratin 13 antibody in craniopharyngiomas were similar to those of non or para-keratinized oral mucosa, but the localization of bcl-2 protein differed. These findings suggest that at least some basal cells of craniopharyngiomas can differentiate to stratified squamous epithelium in a similar way to oral mucosa, but the programmed cell death mechanism might be suppressed in craniopharyn giomas by suprabasal expression of bcl-2 protein.
Lectin histochemistry showed the binding patterns of the basal cells of craniopharyngiomas and the oral mucosa were almost identical. Both were positive for PNA, RCA-I, PSA, and s-WGA, and negative for DBA and SBA, although PNA binding was some what variable. UEA-I was also negative except for one squamous-type tumor. The upper layers above the columnar cells of craniopharyngiomas, however, showed slight differences in binding patterns from those of normal oral mucosa. Craniopharyngiomas showed more restricted affinity to UEA-I, which bound only to the cells around the keratinized granules and sometimes to the surface layer of the squamous areas. One adamantinomatous and one squamous papillary tumor showed no UEA-I bind ing. This may indicate there are fewer fucose residues on the cell membrane or lectin binding to fucose residues is blocked by other carbohydrate residues in craniopharyngiomas.
A similar finding was reported also in ameloblastomas of the jaw.',"' Niikawa et al.24) previously investigated lectin binding to craniopharyngiomas, skin, and epider moid cysts, finding comparable results except for PNA binding. They found suprabasal DBA reactiv ity and Ley antigen only in craniopharyngiomas. DBA binding sites and Ley antigen also occur in the oral mucosa." I The lectin binding profiles of the oral mucosa are different from those seen in other stratified squamous epithelia.',',",",") DBA binds only to the basal cell layer of the skin, and not to the suprabasal layer. 13,22,25,34) Nasopharyngeal squamous epithelium demonstrates RCA-I and UEA-I binding, but not PNA, DBA, and SBA binding." Squamous epithelium in the cervix uteri shows SBA and UEA-I binding in all layers." These differences might be due to variations in the function and differentiation of the squamous epithelium.
The limitation of lectin histochemistry is the sometimes controversial data on binding patterns. For example, several authors reported that PNA bound only to the suprabasal layer of the oral mucosa as in the epidermis,""' but others demonstrated occasional binding to the basal layer as in our study. 10 21,29,33) Saku and Okabe29 proposed that these differences probably depended on the sites of the mucosa. Other factors such as the methods used 2,6,12,31, 34) and blood groups9 might be responsible for the differences. We compared lectin binding pat terns of craniopharyngiomas with those of the oral mucosa obtained from several places using the fixed method. The blood group of each specimen was also considered.
We also investigated the presence of cytokeratin 13 for further confirmation of the similarity between craniopharyngioma and oral mucosa. Cytokeratin 13 is an acidic 51-kd keratin found in the suprabasal layer of the non-keratinized stratified squamous epithelium, such as the esophageal and oral mucosa.5' Cytokeratin 13 immunostaining of the suprabasal cells of craniopharyngiomas demon strated that these cells may be related to the muco sal cells rather than to the epidermal cells, since cytokeratin 13 is considered to be a phenotypic marker .5) Although cytokeratin subfamily expression in craniopharyngiomas has not been investigated in detail, our study revealed that cytokeratin 13 expres sion in craniopharyngiomas was similar to that in non-keratinized stratified squamous epithelium. Expression of bcl-2 protein in neoplasms other than malignant lymphomas has been rarely studied. 15,11,21) Lu et a!.15' reported bcl-2 expression in nasopharyngeal carcinomas, and suggested involve ment in the pathogenesis of epithelial malignancy. Our study demonstrated bcl-2 protein was present in the suprabasal cells of all craniopharyngioma samples, indicating that this protein may be related to the tumorigenesis of this tumor. In contrast, the skin and oral mucosa do not express bcl-2 protein.
Oral mucosa and craniopharyngiomas demonstrate differences in lectin binding and bcl-2 protein expres sion that apparently reflect the differentiation poten tial of the basal cells. UEA-I binding and loss of PSA binding are constantly observed in normal epidermis, oral mucosa, and epidermoid cysts before the terminal differentiation stage. 'o,18,21,22,25,29,33 Cancer 37: 1944 Cancer 37: -1952 Cancer 37: , 1976 Fluorochrome-coupled lectin reveal distinct cellular domains in human epidermis. J Histochem Cytochem 34: [307] [308] [309] [310] [311] [312] [313] [314] [315] 1986 
